Table 1: Demographic, clinical and laboratory characteristics of the study population.

Variable

n (%) or mean ± SD

Mean ± SD Age (years)

58.3 ± 12.4

Age Categories, n (%)

 

 18-40

28 (8.1)

 41-54

100 (28.9)

 ≥ 55

218 (63)

Female Sex, n (%)

209 (60.4)

Place Of Referral, n (%)

 

 Outpatient

305 (88.1)

 Inpatient

41 (11.9)

Cardiovascular Risk Factors, n (%)

 

 Diabetes

44 (12.7)

 Smoking

34 (9.8)

 Alcohol

146 (42.2)

 Family History of Cardiovascular Disease

152 (43.9)

Anthropometric Variables

 

 Mean ± SD Height (cm)

165.2 ± 9.2

 Mean ± SD Weight (kg)

75.9 ± 16.2

 Mean ± SD BMI (kg/m2)

27.8 ± 5.3

Obesity Status, n (%)

 

 Normal Weight

127 (36.7)

 Overweight

113 (32.7)

 Obese

106 (30.6)

Mean ± SD Duration of hypertension

6.8 ± 9.1

Mean ± SD Systolic BP (mmhg)(mmhg)

152 ± 23

Mean ± SD Diastolic BP (mmhg)

91 ± 15

Hypertension Stage, n (%)

 

Normal (Controlled) BP

100 (28.9)

Stage 1

98 (28.3)

Stage 2

85 (24.6)

Stage 3

63 (18.2)

Mean ± SD Pulse Rate (beats/min)

80 ± 15

Tachycardia (≥ 100b/min), n (%)

47 (13.6)

Laboratory Findings

 

 Mean ± SD Triglyceride (mmol/L)

1.5 ± 0.7

Raised Triglyceride, n (%)

120 (34.7)

 Mean ± SD Cholesterol (mmol/L)

5.3 ± 3.4

Raised Cholesterol, n (%)

165 (47.7)

 Mean ± SD LdL-C (mmol/L)

3.6 ± 1.2

Raised LDL-C, n (%)

202 (58.4)

 Mean ± SD HdL-C (mmol/L)

1.1 ± 0.2

Low HDL-C, N (%)

154 (44.5)

 Mean ± Hemoglobin (g/dl)

12.6 ± 2

Anemia, n (%)

110 (31.8)

Mean ± SD eGFR (ml/min/1.73 m2)

72.7 ± 22

Mean ± SD Urea Nitrogen (mmol/L)

10.9 ± 7.7

Proportion With Renal Dysfunction, n (%)

85 (24.5)

BMI: Body Mass Index; BP: Blood Pressure; LDL: Low Density Lipoprotein; HDL: High Density Lipoprotein; eGFR: Estimated Glomerular Filtration Rate